StonvexLoading…
StonvexStonvexStonvexCore line items from ELV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-15 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $49.20B | $50.18B | $199.13B | $149.38B | $98.67B |
Operating Income | Not available | $2.09B | $7.20B | $6.89B | $5.59B |
Net Income | Not available | $1.76B | $5.66B | $5.12B | $3.93B |
EPS (Diluted) | $6.27 | $8.00 | $25.21 | $22.67 | $17.33 |
Total Assets | Not available | $125.83B | $121.49B | $122.75B | $121.94B |
Total Liabilities | Not available | $81.78B | $77.47B | $78.67B | $78.09B |
Cash & Equivalents | Not available | $9.66B | $9.49B | $8.71B | $8.56B |
Free Cash Flow OCF − CapEx | Not available | $4.10B | $3.17B | $3.38B | $2.61B |
Shares Outstanding | Not available | 217.37M | 220.72M | 222.04M | 224.84M |